68770-140 NDC - FLOATER (CHELIDONIUM MAJUS WHOLE, POTASSIUM SULFATE, SODIUM CHLORIDE, PHOSPHORUS, PHYSOSTIGMA VENENOSUM SEED, SEPIA OFFICINALIS JUICE, SILICON DIOXIDE)

Drug Information

Product NDC: 68770-140

Proprietary Name: Floater

Non Proprietary Name: CHELIDONIUM MAJUS WHOLE, POTASSIUM SULFATE, SODIUM CHLORIDE, PHOSPHORUS, PHYSOSTIGMA VENENOSUM SEED, SEPIA OFFICINALIS JUICE, SILICON DIOXIDE

Active Ingredient(s):
  • 6 [hp_X]/1 CHELIDONIUM MAJUS WHOLE;
  • 12 [hp_X]/1 PHOSPHORUS;
  • 12 [hp_X]/1 PHYSOSTIGMA VENENOSUM SEED;
  • 10 [hp_X]/1 POTASSIUM SULFATE;
  • 7 [hp_X]/1 SEPIA OFFICINALIS JUICE;
  • 12 [hp_X]/1 SILICON DIOXIDE;
  • 10 [hp_X]/1 SODIUM CHLORIDE


Administration Route(s): ORAL

Dosage Form(s): PELLET

Pharmacy Class(es):
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC]

Labeler Information

Labeler Name: Natural Ophthalmics, Inc
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:4/27/2022

Package Information

No. Package Code Package Description Billing Unit
168770-140-42600 PELLET in 1 BOTTLE (68770-140-42)

NDC Record

Field Name Field Value Definition
PRODUCT NDC68770-140The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEFloaterThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECHELIDONIUM MAJUS WHOLE, POTASSIUM SULFATE, SODIUM CHLORIDE, PHOSPHORUS, PHYSOSTIGMA VENENOSUM SEED, SEPIA OFFICINALIS JUICE, SILICON DIOXIDEThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEPELLETThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/27/2022This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENatural Ophthalmics, IncName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECHELIDONIUM MAJUS WHOLE; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; POTASSIUM SULFATE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 12; 12; 10; 7; 12; 10 
ACTIVE INGRED UNIT[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 
PHARM CLASSESIncreased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023